Last Monday, i.e on Nov. 21, third parties invested a total of $22,500 into a paid advertising campaign in favor of Viral Genetics, Inc. (PINK:VRAL). As a result, VRAL stock gained 9.6% on Monday and 31.25% on Tuesday, and that was pretty much the end of it.
With no current promotions going on, the situation is much different. While VRAL gained 3% yesterday, closing at $0.0325 per share on a volume of 11.9 million, it had already lost 3% during the previous session, so the last two sessions balance out. In a nutshell, VRAL’s post-promotion market performance has been barely noticeable.
Needless to say, VRAL stock has shown substantial (and fairly short-lived) dependence upon paid promotions. Therefore, stockholders owning VRAL shares currently have no other choice but rely on artificial pumps to realize any profits.
Whether or not this situation will change is still a long shot, the company seems to have made the first step already by moving towards a more transparent policy, which is why a prospective upgrade to a higher marketplace, i.e OTC Pink Current, is definitely a possibility. Another point that requires attention is the company’s revenue drought. With a working capital deficit of $3 million and a net quarterly loss of $1.3 million (as of Jun. 30, 2011), the odds are heavily against VRAL’s going profitable in the foreseeable future.
